Citations (133)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Chaoyang Zhou, Aijun Liang, Jianzhong Zhang, Jingxing Leng, Bin Xi, Bin Zhou, Yu Yang, Ronglan Zhu, Liangchen Zhong, Xingxing Jiang & Dengfeng Wan. (2023) Depleting ANTXR1 suppresses glioma growth via deactivating PI3K/AKT pathway. Cell Cycle 22:19, pages 2097-2112.
Read now
Read now
Vennela Tulluri & Venkatesh V Nemmara. (2021) Role of Antizyme Inhibitor Proteins in Cancers and Beyond. OncoTargets and Therapy 14, pages 667-682.
Read now
Read now
Peng-Fei Wang, Han-Yue Qiu, Yun He & Hai-Liang Zhu. (2020) Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019). Expert Opinion on Therapeutic Patents 30:10, pages 795-805.
Read now
Read now
Sare Hosseini, Jamshidkhan Chamani, Mohammad Reza Hadipanah, Negar Ebadpour, Amir Sajjad Hojjati, Mohammad Hasan Mohammadzadeh & Hamid Reza Rahimi. (2019) Nano-curcumin’s suppression of breast cancer cells (MCF7) through the inhibition of cyclinD1 expression. Breast Cancer: Targets and Therapy 11, pages 137-142.
Read now
Read now
Gabriele Di Sante, Jessica Pagé, Xuanmao Jiao, Omar Nawab, Massimo Cristofanilli, Emmanuel Skordalakes & Richard G Pestell. (2019) Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology. Expert Review of Anticancer Therapy 19:7, pages 569-587.
Read now
Read now
Keke Dong, Xueyu Yang, Tengteng Zhao & Xiaolei Zhu. (2017) An insight into the inhibitory selectivity of 4-(Pyrazol- 4-yl)-pyrimidines to CDK4 over CDK2. Molecular Simulation 43:8, pages 599-609.
Read now
Read now
Polyana Lopes Benfica, Renato Ivan de Ávila, Bruna dos Santos Rodrigues, Alane Pereira Cortez, Aline Carvalho Batista, Marilisa Pedroso Nogueira Gaeti, Eliana Martins Lima, Kênnia Rocha Rezende & Marize Campos Valadares. (2017) 4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line. Pharmaceutical Biology 55:1, pages 1899-1908.
Read now
Read now
Moataz Ehab & Mohamad Elbaz. (2016) Profile of palbociclib in the treatment of metastatic breast cancer. Breast Cancer: Targets and Therapy 8, pages 83-91.
Read now
Read now
Maike Zimmermann, Aruni P. S. Arachchige-Don, Michaela S. Donaldson, Tommaso Patriarchi & Mary C. Horne. (2016) Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival. Cell Cycle 15:23, pages 3278-3295.
Read now
Read now
Articles from other publishers (124)
Dongxian Jiang, Qi Song, Fuhan Zhang, Chen Xu, Xiaojing Li, Haiying Zeng, Jieakesu Su, Jie Huang, Yifan Xu, Shaohua Lu & Yingyong Hou. (2023) Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma. Cancer Genetics 278-279, pages 1-8.
Crossref
Crossref
Mostafa Saleban, Erica L. Harris & James A. Poulter. (2023) D-Type Cyclins in Development and Disease. Genes 14:7, pages 1445.
Crossref
Crossref
Milad Bideh, Samaneh Safari, Azam Khedri & Mohammad Zangooei. (2023) The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha. Molecular Biology Reports.
Crossref
Crossref
Min Yin, Chunli Lu, Huimei Zhou, Qian Liu & Jiaxin Yang. (2023) Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma. BMC Women's Health 23:1.
Crossref
Crossref
Jing Wang, Jiaxin Zhang, Qinglong Ma, Shasha Zhang, Fengdie Ma, Wei Su, Taotao Zhang, Xiaodong Xie & Cuixia Di. (2023)
Influence of cyclin
D1
splicing variants expression on breast cancer chemoresistance via
CDK4
/
CyclinD1‐pRB‐E2F1
pathway
. Journal of Cellular and Molecular Medicine 27:7, pages 991-1005.
Crossref
Crossref
Jinku Zhang, Jirui Sun, Chong Li, Haizhi Qiao & Zahid Hussain. (2023) Functionalization of curcumin nanomedicines: a recent promising adaptation to maximize pharmacokinetic profile, specific cell internalization and anticancer efficacy against breast cancer. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Manzoor Ahmad Mir & Hina Qayoom. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer
355
373
.
Jue Young Kim, Jin Kim, B. M. Ratnayake Bandara, Wanninayake M. Tilakaratne & Dokyeong Kim. (2022) Leaf extract of Osbeckia octandra induces apoptosis in oral squamous cell carcinoma cells. BMC Complementary Medicine and Therapies 22:1.
Crossref
Crossref
Amrita Bhattacharya, Vaibhav Kumar Shukla, Nitin Kachariya, Preeti, Parveen Sehrawat & Ashutosh Kumar. (2022) Disorder in the Human Skp1 Structure is the Key to its Adaptability to Bind Many Different Proteins in the SCF Complex Assembly. Journal of Molecular Biology 434:21, pages 167830.
Crossref
Crossref
Hai-Zhou Wu, Lan-Ya Li, Shi-Long Jiang, Yi-Zhi Li, Xiao-Mei Shi, Xin-Yuan Sun, Zhuo Li & Yan Cheng. (2022) RSK2 promotes melanoma cell proliferation and vemurafenib resistance via upregulating cyclin D1. Frontiers in Pharmacology 13.
Crossref
Crossref
Stephen S. Koh, Sean K. Lau & David S. Cassarino. (2022) Absence of Differential Cyclin D1 Immunohistochemical Protein Expression in Nevi and Melanoma Evaluated by Digital Image Analysis. Applied Immunohistochemistry & Molecular Morphology 30:6, pages 441-445.
Crossref
Crossref
Shuo Xu, Dingsheng Liu, Mingming Cui, Yao Zhang, Yu Zhang, Shiqi Guo & Hong Zhang. (2022) Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma. BioMed Research International 2022, pages 1-21.
Crossref
Crossref
Changjun Wang, Yan Lin, Hanjiang Zhu, Yidong Zhou, Feng Mao, Xin Huang, Qiang Sun & Chenggang Li. (2022) Efficacy and Safety Profile of Histone Deacetylase Inhibitors for Metastatic Breast Cancer: A Meta-Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Ying Liu, Guangwei Ma, Zenghong Gao, Jian Li, Jin Wang, Xiangping Zhu, Ruowu Ma, Jiawen Yang, Yiting Zhou, Kaishun Hu, Yin Zhang & Yabin Guo. (2022) Global chromosome rearrangement induced by CRISPR-Cas9 reshapes the genome and transcriptome of human cells. Nucleic Acids Research 50:6, pages 3456-3474.
Crossref
Crossref
Xiaojing Wang, Linchuan Ma, Jingmin Li & Fanzhen Kong. (2022) Activated cell-cycle CDK4/CyclinD1-pRB-E2F1 signaling pathway is involved in the apoptosis of dorsal raphe nucleus in the rat model of PTSD. Biochemical and Biophysical Research Communications 602, pages 142-148.
Crossref
Crossref
Yuwen Jiang, Chenlu Zhang, Ling Lu, Xinfeng Wang, Haiyan Liu, Yijing Jiang, Lemin Hong, Yifan Chen, Hongming Huang & Dan Guo. (2022) The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis. Technology in Cancer Research & Treatment 21, pages 153303382110652.
Crossref
Crossref
Yuxue Wang, Yi Liu, Lei Xiang, Lintao Han, Xiaowei Yao, Yibing Hu & Fenghua Wu. (2021) Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis. Experimental Biology and Medicine 246:24, pages 2559-2569.
Crossref
Crossref
Ziyi Zhao, Jinhao Zeng, Qiang Guo, Kunming Pu, Yi Yang, Nianzhi Chen, Gang Zhang, Maoyuan Zhao, Qiao Zheng, Jianyuan Tang & Qiongying Hu. (2021) Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation. Frontiers in Oncology 11.
Crossref
Crossref
Jaqueline Ferreira Campos, Helder Freitas dos Santos, Thaliny Bonamigo, Nelson Luís de Campos Domingues, Kely de Picoli Souza & Edson Lucas dos Santos. (2021) Stingless Bee Propolis: New Insights for Anticancer Drugs. Oxidative Medicine and Cellular Longevity 2021, pages 1-18.
Crossref
Crossref
Farzad Rahmani, Milad Hashemzehi, Amir Avan, Farnaz Barneh, Fereshteh Asgharzadeh, Reyhaneh Moradi Marjaneh, Atena Soleimani, Mohammadreza Parizadeh, Gordon A. Ferns, Majid Ghayour Mobarhan, Mikhail Ryzhikov, Amir Reza Afshari, Mohammad Reza Ahmadian, Elisa Giovannetti, Mohieddin Jafari, Majid Khazaei & Seyed Mahdi Hassanian. (2021) Rigosertib elicits potent anti-tumor responses in colorectal cancer by inhibiting Ras signaling pathway. Cellular Signalling 85, pages 110069.
Crossref
Crossref
Ki-Tae Hwang, Young A. Kim, Jongjin Kim, Hyeon Jeong Oh, Jeong Hwan Park, In Sil Choi, Jin Hyun Park, Sohee Oh, Ajung Chu, Jong Yoon Lee & Kyu Ri Hwang. (2021) Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer. Scientific Reports 11:1.
Crossref
Crossref
Ya Chun Yu, Jung Min Han & Sunghoon Kim. (2021) Aminoacyl-tRNA synthetases and amino acid signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1868:1, pages 118889.
Crossref
Crossref
Yang Zheng, An Song, Yan Zhou, Yi Zhong, Wei Zhang, Chundi Wang, Xu Ding, Yifei Du, Wei Zhang, Gang Li, Heming Wu, Yunong Wu & Xiaomeng Song. (2020) Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma. Journal of Cell Communication and Signaling 14:4, pages 389-402.
Crossref
Crossref
Farzad Rahmani, Ayda Tadayyon Tabrizi, Pedram Hashemian, Sajede Alijannejad, Hossein Ali Rahdar, Gordon A Ferns, Seyed Mahdi Hassanian, Soodabeh Shahidsales & Amir Avan. (2020) Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer. Gene 754, pages 144892.
Crossref
Crossref
Ke Chen, Xuanmao Jiao, Agnese Di Rocco, Duanwen Shen, Shaohua Xu, Adam Ertel, Zuoren Yu, Gabriele Di Sante, Min Wang, Zhiping Li, Timothy G. Pestell, Mathew C. Casimiro, Emmanuel Skordalakes, Samuel Achilefu & Richard G. Pestell. (2020) Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation. Cell Reports 32:11, pages 108151.
Crossref
Crossref
Jamal Hallajzadeh, Parisa Maleki Dana, Moein Mobini, Zatollah Asemi, Mohammad Ali Mansournia, Mehran Sharifi & Bahman Yousefi. (2020) Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer. Medical Oncology 37:6.
Crossref
Crossref
Xiao Yan, Minjie Gao, Ping Zhang, Guifang Ouyang, Qitian Mu & Kaihong Xu. (2020) MiR‑181a functions as an oncogene by regulating CCND1 in multiple myeloma. Oncology Letters.
Crossref
Crossref
Bo Yan, Yan Li, Shaoju Min, Peng Zhang, Bin Xu, Zhen Wang, Wei Zhang, Jiasheng Chen, Guangheng Luo & Chunxiao Liu. (2020) Effects of the Bone/Bone Marrow Microenvironments on Prostate Cancer Cells and CD59 Expression. BioMed Research International 2020, pages 1-13.
Crossref
Crossref
Arndt Wallmann & Christopher Kesten. (2020) Common Functions of Disordered Proteins across Evolutionary Distant Organisms. International Journal of Molecular Sciences 21:6, pages 2105.
Crossref
Crossref
Shan Xu, Haibao Zhang, Tianjie Liu, Wenjie Yang, Wei Lv, Dalin He, Peng Guo & Lei Li. (2019) 6-Gingerol induces cell-cycle G1-phase arrest through AKT–GSK 3β–cyclin D1 pathway in renal-cell carcinoma. Cancer Chemotherapy and Pharmacology 85:2, pages 379-390.
Crossref
Crossref
Hongli Jiang, Jie Li, Xin He, Jinhong Xue, Shanshan Liang, Sixiu Liu, Fanfan Gao, Ning Qu, Hua Liu & Lei Chen. (2019) D-site binding protein regulates cell proliferation through mediating cell cycle progression in rat mesangial cells. Tissue and Cell 61, pages 35-43.
Crossref
Crossref
Yao Chen, Xudan Liu, Huanhuan Wang, Shiyi Liu, Nannan Hu & Xin Li. (2019) Akt Regulated Phosphorylation of GSK-3β/Cyclin D1, p21 and p27 Contributes to Cell Proliferation Through Cell Cycle Progression From G1 to S/G2M Phase in Low-Dose Arsenite Exposed HaCat Cells. Frontiers in Pharmacology 10.
Crossref
Crossref
Rui Zhou, Ka Wu, Min Su & Rong Li. (2019) Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma. Environmental Toxicology and Pharmacology 70, pages 103200.
Crossref
Crossref
Karen Udoh, Seema Parte, Kelsey Carter, Aaron Mack & Sham S. Kakar. (2019) Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J. Stem Cell Reviews and Reports 15:4, pages 601-611.
Crossref
Crossref
Ramona Palombo, Paola Frisone, Marco Fidaleo, Neri Mercatelli, Claudio Sette & Maria Paola Paronetto. (2019)
The Promoter-Associated Noncoding RNA
pncCCND1_B
Assembles a Protein–RNA Complex to Regulate Cyclin D1 Transcription in Ewing Sarcoma
. Cancer Research 79:14, pages 3570-3582.
Crossref
Crossref
Liliia Zvarych, Nataliya Golyarnik & Iryna Ilienko. (2019) Level of Cyclin D1 protein in peripheral blood lymphocytes of Chornobyl clean-up workers in remote period after radiation exposure. ScienceRise: Biological Science 0:2 (17), pages 4-9.
Crossref
Crossref
Suihai Wang, Xiaobo Wang, Yanjun Gao, Yingxia Peng, Ningning Dong, Qian Xie, Xian Zhang, Yingsong Wu, Ming Li & Ji‐Liang Li. (2019) RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK–cyclin D1/CDK4 pathway. The Journal of Pathology 248:2, pages 204-216.
Crossref
Crossref
Jiarong Lan, Min Li & Haifeng Wang. (2019)
CCDN1
rs603965 polymorphism may serve as a genetic biomarker of brain tumor: A meta‐analysis of 5,769 subjects
. Molecular Genetics & Genomic Medicine 7:6.
Crossref
Crossref
P. V Bhagwanrao, P. G. Ingole & S. R Butle. (2019) SYNTHESIS AND BIOLOGICAL EVALUATION OF 2-PHENYLPYRIDO[2,3-D] PYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS. INDIAN DRUGS 56:05, pages 50-58.
Crossref
Crossref
Michelle L. Pleet, Catherine DeMarino, Spencer W. Stonier, John M. Dye, Steven Jacobson, M. Javad Aman & Fatah Kashanchi. (2019) Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion. Viruses 11:5, pages 410.
Crossref
Crossref
Taylor Harding, Linda Baughn, Shaji Kumar & Brian Van Ness. (2019) The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies. Leukemia 33:4, pages 863-883.
Crossref
Crossref
Qiu Xiang, Juan Tang, Qin Luo, Jinfeng Xue, Yexing Tao, Honghui Jiang, Jing Tian & Caiwen Fan. (2019) In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG). Biomedicine & Pharmacotherapy 111, pages 813-820.
Crossref
Crossref
Stephane Thibault, Wenyue Hu, Brad Hirakawa, Dalia Kalabat, Tania Franks, Tae Sung, Su Khoh-Reiter, Shuyan Lu, Martin Finkelstein, Bart Jessen & Aida Sacaan. (2019) Intestinal Toxicity in Rats Following Administration of CDK4/6 Inhibitors Is Independent of Primary Pharmacology. Molecular Cancer Therapeutics 18:2, pages 257-266.
Crossref
Crossref
Jaqueline Cristina Fernandes, Ana Paula Nunes Rodrigues Alves, Juan Luiz Coelho-Silva, Renata Scopim-Ribeiro, Bruna Alves Fenerich, Belinda Pinto Simões, Eduardo Magalhães Rego, João Agostinho Machado-Neto & Fabiola Traina. (2018) Increased levels of cyclin D1 negatively impacts on acute lymphoblastic leukemia overall survival. Applied Cancer Research 38:1.
Crossref
Crossref
Donghui Bian, Yan Wu & Guodong Song. (2018) Novel circular RNA, hsa_circ_0025039 promotes cell growth, invasion and glucose metabolism in malignant melanoma via the miR-198/CDK4 axis. Biomedicine & Pharmacotherapy 108, pages 165-176.
Crossref
Crossref
Xinsheng Lin, Guofeng Wen, Shuangle Wang, Hangui Lu, Chuangwei Li & Xin Wang. (2018) Expression and role of EGFR, cyclin�D1 and KRAS in laryngocarcinoma tissues. Experimental and Therapeutic Medicine.
Crossref
Crossref
Michelle L Pleet, James Erickson, Catherine DeMarino, Robert A Barclay, Maria Cowen, Benjamin Lepene, Janie Liang, Jens H Kuhn, Laura Prugar, Spencer W Stonier, John M Dye, Weidong Zhou, Lance A Liotta, M Javad Aman & Fatah Kashanchi. (2018) Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles. The Journal of Infectious Diseases 218:suppl_5, pages S365-S387.
Crossref
Crossref
Nilesh Sudhakar Ambhore, Rathnavali Katragadda, Rama Satyanarayana Raju Kalidhindi, Michael A. Thompson, Christina M. Pabelick, Y.S. Prakash & Venkatachalem Sathish. (2018) Estrogen receptor beta signaling inhibits PDGF induced human airway smooth muscle proliferation. Molecular and Cellular Endocrinology 476, pages 37-47.
Crossref
Crossref
Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Mohamed S.A. Elsayed & Walid M. Ghorab. (2018) Design, synthesis and molecular modeling study of certain 4-Methylbenzenesulfonamides with CDK2 inhibitory activity as anticancer and radio-sensitizing agents. Bioorganic Chemistry 80, pages 276-287.
Crossref
Crossref
Nam Hoon Kwon, Jin Young Lee, Ye-lim Ryu, Chanhee Kim, Jiwon Kong, Seongeun Oh, Beom Sik Kang, Hye Won Ahn, Sung Gwe Ahn, Joon Jeong, Hoi Kyoung Kim, Jong Hyun Kim, Dae Young Han, Min Chul Park, Doyeun Kim, Ryuichi TakaseIsao MasudaYa-Ming HouSung Ill Jang, Yoon Soo Chang, Dong Ki Lee, Youngeun Kim, Ming-Wei Wang, Basappa & Sunghoon Kim. (2018)
Stabilization of Cyclin-Dependent Kinase 4 by Methionyl-tRNA Synthetase in p16
INK4a
-Negative Cancer
. ACS Pharmacology & Translational Science 1:1, pages 21-31.
Crossref
Crossref
Robert Albero, Anna Enjuanes, Santiago Demajo, Giancarlo Castellano, Magda Pinyol, Noelia García, Cristina Capdevila, Guillem Clot, Helena Suárez-Cisneros, Mariko Shimada, Kennosuke Karube, Mónica López-Guerra, Dolors Colomer, Sílvia Beà, José Ignacio Martin-Subero, Elías Campo & Pedro Jares. (2018) Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms. Journal of Clinical Investigation 128:9, pages 4132-4147.
Crossref
Crossref
Erlinda Gordon, Joshua Ravicz, Seiya Liu, Sant Chawla & Frederick Hall. (2018) Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad‑spectrum cancer gene therapy - A review of molecular mechanisms for oncologists. Molecular and Clinical Oncology.
Crossref
Crossref
Elaine Vickers. 2018. A Beginner's Guide to Targeted Cancer Treatments. A Beginner's Guide to Targeted Cancer Treatments
33
63
.
Solomon Habtemariam & Giovanni Lentini. (2018) Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin. Biomedicines 6:2, pages 39.
Crossref
Crossref
Shiri Klein, Michal Abraham, Baruch Bulvik, Elia Dery, Ido D. Weiss, Neta Barashi, Rinat Abramovitch, Hanna Wald, Yaniv Harel, Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Yaron Pereg & Amnon Peled. (2018) CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways. Cancer Research 78:6, pages 1471-1483.
Crossref
Crossref
Lan Wang, Hui Yang, Linli Hu, Dan Hu, Shuxia Ma, Xuejiao Sun, Liu Jiang, Jianyuan Song, Licheng Ji, Jackson Ferdinand Masau, Hanwang Zhang & Kun Qian. (2018) CDKN1C (P57): one of the determinants of human endometrial stromal cell decidualization. Biology of Reproduction 98:3, pages 277-285.
Crossref
Crossref
Yanhong Yang, Wenwen Zhou, Jiandong Wu, Lixin Yao, Lei Xue, Qianyi Zhang, Zhenzhen Wang, Xiaoyu Wang, Shu Dong, Jiangman Zhao & Duanduan Yin. (2018) Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in�vitro. Oncology Letters.
Crossref
Crossref
Yunfeng LiKai JinEric BunkerXiaojuan ZhangXuemei Luo, Xuedong LiuBing Hao. (2017)
Structural basis of the phosphorylation-independent recognition of cyclin D1 by the SCF
FBXO31
ubiquitin ligase
. Proceedings of the National Academy of Sciences 115:2, pages 319-324.
Crossref
Crossref
Vincent W. Yang. 2018. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
197
219
.
Gabriele Di Sante, Mathew C. Casimiro, Zhiping Li, Adam Ertel, Peter Tompa & Richard G. Pestell. 2018. D-type Cyclins and Cancer. D-type Cyclins and Cancer
61
90
.
Lingdi Ma, Zhenyu Xu, Jian Wang, Zhichao Zhu, Guibin Lin, Lijia Jiang, Xuzhang Lu & Chang Zou. (2017) Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells. Oncotarget 8:65, pages 108880-108889.
Crossref
Crossref
Ming Cong, Lili Wen, Fang Han, Yanhao Xu & Yuxiu Shi. (2017) Alterations in cyclin D1 and cyclin-dependent kinase 4 expression in the amygdalae of post-traumatic stress disorder rats. Molecular Medicine Reports 16:6, pages 8351-8358.
Crossref
Crossref
H Ruan, Y Y Zhan, J Hou, B Xu, B Chen, Y Tian, D Wu, Y Zhao, Y Zhang, X Chen, P Mi, L Zhang, S Zhang, X Wang, H Cao, W Zhang, H Wang, H Li, Y Su, X K Zhang & T Hu. (2017) Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells. Oncogene 36:50, pages 6906-6918.
Crossref
Crossref
Andrea Bistrović, Anja Harej, Petra Grbčić, Mirela Sedić, Sandra Kraljević Pavelić, Mario Cetina & Silvana Raić-Malić. (2017) Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases. International Journal of Molecular Sciences 18:11, pages 2292.
Crossref
Crossref
Aida I. Sacaan, Stephane Thibault, Miyoun Hong, Nagesha G. Kondegowda, Tim Nichols, Rosemary Li, Carolina Rosselot, Winston Evering, Rafael Fenutria, Allison Vitsky, Thomas Brown, Martin Finkelstein, Adolfo Garcia-Ocaña, Nasir Khan, Andrew F. Stewart & Rupangi C. Vasavada. (2017) CDK4/6 Inhibition on Glucose and Pancreatic Beta Cell Homeostasis in Young and Aged Rats. Molecular Cancer Research 15:11, pages 1531-1541.
Crossref
Crossref
Simon Body, Anna Esteve-Arenys, Hadjer Miloudi, Clara Recasens-Zorzo, Guergana Tchakarska, Alexandra Moros, Sophie Bustany, Anna Vidal-Crespo, Vanina Rodriguez, Régis Lavigne, Emmanuelle Com, Isolda Casanova, Ramón Mangues, Oliver Weigert, Alejandra Sanjuan-Pla, Pablo Menéndez, Bénédicte Marcq, Jean-Michel Picquenot, Patricia Pérez-Galán, Fabrice Jardin, Gaël Roué & Brigitte Sola. (2017) Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells. Scientific Reports 7:1.
Crossref
Crossref
Gabriele Di Sante, Agnese Di Rocco, Claudia Pupo, Mathew C. Casimiro & Richard G. Pestell. (2017) Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer. Oncotarget 8:47, pages 81803-81812.
Crossref
Crossref
Larissa Sena Teixeira Mendes, Natalie Peters, Ayoma D Attygalle & Andrew Wotherspoon. (2017) Cyclin D1 overexpression in proliferation centres of small lymphocytic lymphoma/chronic lymphocytic leukaemia. Journal of Clinical Pathology 70:10, pages 899-902.
Crossref
Crossref
Zhao Xiang, Zhang Liang, Huang Yanfeng & Kang Leitao. (2017) Persistence of RSV promotes proliferation and epithelial-mesenchymal transition of bronchial epithelial cells through Nodal signaling. Journal of Medical Microbiology 66:10, pages 1499-1505.
Crossref
Crossref
Chang Lee, Juhwa Baek & Sun-Young Han. (2017) The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment. Molecules 22:9, pages 1411.
Crossref
Crossref
Mahmoud Dabbah, Oshrat Attar-Schneider, Shelly Tartakover Matalon, Irit Shefler, Osnat Jarchwsky Dolberg, Michael Lishner & Liat Drucker. (2017) Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells’ phenotype and translation initiation. Carcinogenesis 38:7, pages 708-716.
Crossref
Crossref
Ning Yang, Nannan Yao, Xiangzhi Liao, Xiaona Xie, Yan Wu, Chuanxi Fan, Jialiang Zhao & Guiying Li. (2017) Effects of metal ions on the structure and activity of a human anti-cyclin D1 single-chain variable fragment AD5. Molecular Medicine Reports.
Crossref
Crossref
Zhen-Qiang Wang, Qiang Cai, Lei Hu, Chang-Yu He, Jian-Fang Li, Zhi-Wei Quan, Bing-Ya Liu, Chen Li & Zheng-Gang Zhu. (2017) Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. Cell Death & Disease 8:6, pages e2839-e2839.
Crossref
Crossref
Zixuan Li, Lianyue Qu, Wenting Luo, Yulong Tian, Huan Zhai, Ke Xu & Hongshan Zhong. (2017) Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK/Cyclin D1 pathway. Experimental and Molecular Pathology 102:3, pages 492-499.
Crossref
Crossref
Maria Alba Dosil, Cristina Mirantes, Núria Eritja, Isidre Felip, Raúl Navaridas, Sònia Gatius, Maria Santacana, Eva Colàs, Cristian Moiola, Joan Antoni Schoenenberger, Mario Encinas, Eloi Garí, Xavier Matias-Guiu & Xavier Dolcet. (2017)
Palbociclib has antitumour effects on
Pten-
deficient endometrial neoplasias
. The Journal of Pathology 242:2, pages 152-164.
Crossref
Crossref
Haewon Kim, Chang Hee Jeong, Hong Gu Lee & Sung Gu Han. (2017) Comparison of trans-fatty acids on proliferation and migration of vascular smooth muscle cells. Food Science and Biotechnology 26:2, pages 501-505.
Crossref
Crossref
Christopher R. CoxonElizabeth AnscombeSuzannah J. Harnor, Mathew P. MartinBenoit CarbainBernard T. GoldingIan R. HardcastleLisa K. HarlowSvitlana KorolchukChristopher J. MathesonDavid R. NewellMartin E. M. NobleMangaleswaran SivaprakasamSusan J. TudhopeDavid M. TurnerLan Z. WangStephen R. WedgeChristopher WongRoger J. GriffinJane A. EndicottCéline Cano. (2017) Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines. Journal of Medicinal Chemistry 60:5, pages 1746-1767.
Crossref
Crossref
Jian Huang, Guozhen Yang, Yunzhu Huang & Shu Zhang. (2017) Inhibitory effects of 1,25(OH)2D3 on the proliferation of hepatocellular carcinoma cells through the downregulation of HDAC2. Oncology Reports 38:3, pages 1845-1850.
Crossref
Crossref
Yongtao Zhang, Yuqian Cui, Wei Deng, Hao Wang, Weidong Qin, Chengmin Huang, Chen Li, Jianning Zhang, Yuan Guo, Dawei Wu & Haipeng Guo. (2017) Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation. Clinical and Experimental Pharmacology and Physiology 44:3, pages 362-370.
Crossref
Crossref
Shiqiao Qiu, Jing Liu & Feiyue Xing. (2017) Antizyme inhibitor 1: a potential carcinogenic molecule. Cancer Science 108:2, pages 163-169.
Crossref
Crossref
Lukasz Czerwonka, Nidal Muhanna & Jeremy Freeman. 2017. Medical and Surgical Treatment of Parathyroid Diseases. Medical and Surgical Treatment of Parathyroid Diseases
393
411
.
Mathew C. Casimiro, Richard G. Pestell & Erik S. Knudsen. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets
989
996
.
Shuo Qie & J. Alan Diehl. (2016) Cyclin D1, cancer progression, and opportunities in cancer treatment. Journal of Molecular Medicine 94:12, pages 1313-1326.
Crossref
Crossref
Ying Wang, Wing Lam, Shao-Ru Chen, Fu-Lan Guan, Ginger E. Dutchman, Samson Francis, David C. Baker & Yung-Chi Cheng. (2016) Tylophorine Analog DCB-3503 Inhibited Cyclin D1 Translation through Allosteric Regulation of Heat Shock Cognate Protein 70. Scientific Reports 6:1.
Crossref
Crossref
Rui-Ting Liu, Guo-Rong Wang, Chang Liu, Jian Qiu, Li-Kun Yan, Xiao-Jun Li & Xiao-Qiang Wang. (2016) RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer. International Journal of Molecular Medicine 38:3, pages 703-712.
Crossref
Crossref
Deguang Kong, Yu Liu, Qian Liu, Na Han, Cuntai Zhang, Richard G. Pestell, Kongming Wu & Gaosong Wu. (2016) The retinal determination gene network: from developmental regulator to cancer therapeutic target. Oncotarget 7:31, pages 50755-50765.
Crossref
Crossref
Xi Xia, Yang Yu, Li Zhang, Yang Ma & Hong Wang. (2016) Inhibitor of DNA binding 1 regulates cell cycle progression of endothelial progenitor cells through induction of Wnt2 expression. Molecular Medicine Reports.
Crossref
Crossref
Xiaoyu Wu, Wentao Liu, Ding Tang, Haijuan Xiao, Zhenfeng Wu, Che Chen, Xuequan Yao, Fukun Liu & Gang Li. (2016) Prognostic values of four Notch receptor mRNA expression in gastric cancer. Scientific Reports 6:1.
Crossref
Crossref
Dongbin Bi, Hao Ning, Shuai Liu, Xinxiang Que & Kejia Ding. (2016) miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C. Biomedicine & Pharmacotherapy 81, pages 25-30.
Crossref
Crossref
Haidong Bao, Peng Liu, Ke Jiang, Xianbin Zhang, Long Xie, Zhongyu Wang & Peng Gong. (2016) Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncology Letters.
Crossref
Crossref
Siwanon Jirawatnotai & Gunya Sittithumcharee. (2016) Paradoxical roles of cyclin D1 in DNA stability. DNA Repair 42, pages 56-62.
Crossref
Crossref
Hope S. RugoNeelima VidulaCynthia Ma. (2016) Improving Response to Hormone Therapy in Breast Cancer: New Targets, New Therapeutic Options. American Society of Clinical Oncology Educational Book:36, pages e40-e54.
Crossref
Crossref
Alessandra Nigro, Loredana Mauro, Francesca Giordano, Salvatore Panza, Rina Iannacone, Grazia Maria Liuzzi, Saveria Aquila, Francesca De Amicis, Francesco Cellini, Cesare Indiveri & Maria Luisa Panno. (2016) Recombinant Arabidopsis HSP70 Sustains Cell Survival and Metastatic Potential of Breast Cancer Cells. Molecular Cancer Therapeutics 15:5, pages 1063-1073.
Crossref
Crossref
Bo Mi Ku, Seong Yoon Yi, Jiae Koh, Yeon-Hee Bae, Jong-Mu Sun, Se-hoon Lee, Jin Seok Ahn, Keunchil Park & Myung-Ju Ahn. (2016) The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma. Oncotarget 7:12, pages 14803-14813.
Crossref
Crossref
Xiaoxu Zhou, Jun Cui, Shikai Liu, Derong Kong, He Sun, Chenlei Gu, Hongdi Wang, Xuemei Qiu, Yaqing Chang, Zhanjiang Liu & Xiuli Wang. (2016)
Comparative transcriptome analysis of papilla and skin in the sea cucumber,
Apostichopus japonicus
. PeerJ 4, pages e1779.
Crossref
Crossref
Sukhbir Kaur, Abdel G. Elkahloun, Satya P. Singh, Qing-Rong Chen, Daoud M. Meerzaman, Timothy Song, Nidhi Manu, Weiwei Wu, Poonam Mannan, Susan H. Garfield & David D. Roberts. (2016) A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer. Oncotarget 7:9, pages 10133-10152.
Crossref
Crossref
Archana Balakrishnan, Arpita Vyas, Kaivalya Deshpande & Dinesh Vyas. (2016) Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer. World Journal of Gastroenterology 22:7, pages 2159-2164.
Crossref
Crossref
Neelima Vidula & Hope S. Rugo. (2016) Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data. Clinical Breast Cancer 16:1, pages 8-17.
Crossref
Crossref
Kazushi InoueElizabeth A. Fry. (2016) Novel Molecular Markers for Breast Cancer. Biomarkers in Cancer 8, pages BIC.S38394.
Crossref
Crossref
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO & NAOKI ISHIGE. (2016) FH535 suppresses the proliferation and motility of hepatocellular carcinoma cells. International Journal of Oncology 48:1, pages 110-114.
Crossref
Crossref
Mathew C. Casimiro, Richard G. Pestell & Erik S. Knudsen. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets
1
8
.
Ming Zong, Tianbao Lu, Shasha Fan, Hui Zhang, Ruhan Gong, Lishan Sun, Zhiyan Fu & Lieying Fan. (2015) Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Raghvendra K. DubeyJürgen FingerleDelbert G. GillespieZaichuan MiMarinella RosselliBruno ImthurnEdwin K. Jackson. (2015) Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D. Hypertension 66:6, pages 1207-1219.
Crossref
Crossref
L. Pan, X. Ma, B. Wen, Z. Su, X. Zheng, Y. Liu, H. Li, Y. Chen, J. Wang, F. Lu, J. Qu & L. Hou. (2015) Microphthalmia-associated transcription factor/T-box factor-2 axis acts through Cyclin D1 to regulate melanocyte proliferation. Cell Proliferation 48:6, pages 631-642.
Crossref
Crossref
Wenhu Huang, Walter ColletteIIIIII, Michelle Twamley, Shirley A. Aguirre & Aida Sacaan. (2015) Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in rats. Toxicology and Applied Pharmacology 289:3, pages 525-533.
Crossref
Crossref
Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto & Naoki Ishige. (2015) Suppressive effects of 3-bromopyruvate on the proliferation and the motility of hepatocellular carcinoma cells. Oncology Reports.
Crossref
Crossref
Tim Dukelow, Divya Kishan, Mustafa Khasraw & Conleth G. Murphy. (2015) CDK4/6 inhibitors in breast cancer. Anti-Cancer Drugs 26:8, pages 797-806.
Crossref
Crossref
Vincent Gleize, Agusti Alentorn, Léa Connen de Kérillis, Marianne Labussière, Aravidan A Nadaradjane, Emeline Mundwiller, Chris Ottolenghi, Stephanie Mangesius, Amithys Rahimian, François Ducray, Karima Mokhtari, Chiara Villa & Marc Sanson. (2015)
C
IC
inactivating mutations identify aggressive subset of 1p19q codeleted gliomas
. Annals of Neurology 78:3, pages 355-374.
Crossref
Crossref
Fernanda Gonçalves de Andrade, Suely Kazue Nagahashi Marie, Miyuki Uno, Hamilton Matushita, Mario Augusto Taricco, Manoel Jacobsen Teixeira, Sergio Rosemberg & Sueli Mieko Oba-Shinjo. (2015) Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases. Neuropathology 35:4, pages 312-323.
Crossref
Crossref
Weilong Yao, Ping Yue, Guojing Zhang, Taofeek K. Owonikoko, Fadlo R. Khuri & Shi-Yong Sun. (2015) Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells. Cancer Letters 364:1, pages 70-78.
Crossref
Crossref
KHALDA FADLALLA, RAMY ELGENDY, EBONY GILBREATH, SATYANARAYANA R PONDUGULA, TESHOME YEHUALAESHET, MAHMOUD MANSOUR, TESFAYE SERBESSA, UPENDER MANNE & TEMESGEN SAMUEL. (2015) 3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation. Oncology Reports 34:1, pages 495-503.
Crossref
Crossref
Peng Wu, Thomas E. Nielsen & Mads H. Clausen. (2015) FDA-approved small-molecule kinase inhibitors. Trends in Pharmacological Sciences 36:7, pages 422-439.
Crossref
Crossref
Mathew C. Casimiro, Gabriele Di Sante, Marco Crosariol, Emanuele Loro, William Dampier, Adam Ertel, Zuoren Yu, Elizabeth A. Saria, Alexandros Papanikolaou, Zhiping Li, Chenguang Wang, Sankar Addya, Michael P. Lisanti, Paolo Fortina, Robert D. Cardiff, Aydin Tozeren, Erik S. Knudsen, Andrew Arnold & Richard G. Pestell. (2015) Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget 6:11, pages 8525-8538.
Crossref
Crossref
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO & NAOKI ISHIGE. (2015) Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA. International Journal of Oncology 46:3, pages 1018-1024.
Crossref
Crossref
Kazushi InoueElizabeth A. Fry. (2015) Aberrant Expression of Cyclin D1 in Cancer. Signal Transduction Insights 4, pages STI.S30306.
Crossref
Crossref
Chengshuo Zhang, Jialin Zhang, Xin Li, Ning Sun, Rui Yu, Bochao Zhao, Dongyang Yu, Ying Cheng & Yongfeng Liu. (2015) Huaier Aqueous Extract Induces Hepatocellular Carcinoma Cells Arrest in S Phase via JNK Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-11.
Crossref
Crossref
Andrew Arnold & Michael A. Levine. 2015. The Parathyroids. The Parathyroids
279
296
.
Mathew C. Casimiro, Richard G. Pestell & Erik S. Knudsen. 2015. Cancer Therapeutic Targets. Cancer Therapeutic Targets
1
8
.
Xun Yuan, Hua Wu, Na Han, Hanxiao Xu, Qian Chu, Shiying Yu, Yuan Chen & Kongming Wu. (2014) Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. Journal of Hematology & Oncology 7:1.
Crossref
Crossref
Zhigang Li, Xinxin Li, Chunguang Li, Yinghan Su, Wentao Fang, Chenxi Zhong, Weidan Ji, Qian Zhang & Changqing Su. (2014) Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma. Cancer Letters 354:1, pages 77-86.
Crossref
Crossref
Nuha Al-Zaubai, Cameron N. Johnstone, May May Leong, John Li, Mark Rizzacasa & Alastair G. Stewart. (2014) Resolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor. Journal of Pharmacology and Experimental Therapeutics 351:1, pages 172-180.
Crossref
Crossref
Caitlin Fujisawa & John J. CastellotJrJr. (2014) Matrix production and remodeling as therapeutic targets for uterine leiomyoma. Journal of Cell Communication and Signaling 8:3, pages 179-194.
Crossref
Crossref
Armel Hervé Nwabo Kamdje. (2014) New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers. World Journal of Clinical Cases 2:12, pages 769.
Crossref
Crossref
Dongxian Jiang, Qi Song, Fuhan Zhang, Chen Xu, Xiaojing Li, Haiying Zeng, Jieakesu Su, Jie Huang, Yifan Xu, Shaohua Lu & Yingyong Hou. (2022) CCND1 Amplification/Overexpression Impact Prognosis of Esophageal Squamous Cell Carcinoma Patients with Smoking. SSRN Electronic Journal.
Crossref
Crossref